- Ocera Therapeutics Inc OCRX shares dropped 68.3 percent to $0.650 after the company reported top-line results for Phase 2b study in Hepatic Encephalopathy.
- Regulus Therapeutics Inc RGLS shares declined 50 percent to $1.12 after the company received a written communication from the U.S. Food and Drug Administration that the clinical development for the company's RG-101 remains on clinical hold.
- Pulmatrix Inc PULM declined 27.9 percent to $2.43 after surging 51.80 percent on Friday. Pulmatrix reported a $5 million registered direct offering.
- Tempur Sealy International Inc TPX shares dipped 27.6 percent to $45.74 following announcement of termination of Mattress Firm MFRM contracts.
- Opus Bank OPB fell 23.9 percent to $20.75. Opus Bank reported a Q4 loss of $0.55 per share.
- Rite Aid Corporation RAD dropped 16.4 percent to $5.79. In a merger amendment publicized Monday morning, Walgreens Boots Alliance Inc WBA and Rite Aid agreed to reduce the value of Rite Aid shares between $6.50 and $7 and to divest a total of 1,200 stores. The initial agreement proposed a divestment of 1,000. The companies also announced the extension of the transaction deadline to July 31.
- Rewalk Robotics Ltd RWLK fell 13 percent to $2.00. Rewalk Robotics shares have declined 77.02 percent over the past 52 weeks, while the S&P 500 index has gained 18.32 percent in the same period.
- Fitbit Inc FIT shares tumbled 12.1 percent to $6.34 after the company surprised investors with a downward revision to its fourth-quarter guidance and a plan to slash around 6 percent of its total workforce.
- Costamare Inc CMRE declined 10.3 percent to $5.39. Credit Suisse downgraded Costamare from Neutral to Underperform.
- Globus Maritime Ltd GLBS shares dropped 10 percent to $8.48 after rising 3.51 percent on Friday.
- Enbridge Energy Partners, L.P. EEP declined 9.4 percent to $19.33. Mizuho downgraded Enbridge Energy Partners from Buy to Neutral and lowered the price target from $29.00 to $22.00.
- Booz Allen Hamilton Holding Corporation BAH dropped 8.3 percent to $33.25 after the company reported weaker-than-expected earnings for its third quarter.
- Array Biopharma Inc ARRY declined 7.3 percent to $10.38. Leerink Swann downgraded Array Biopharma from Outperform to Market Perform.
- FibroGen Inc FGEN fell 6.7 percent to $21.75. FibroGen disclosed that FG-4592 has met primary endpoints in two Phase 3 anemia studies in China.
- Rowan Companies PLC RDC slipped 6.5 percent to $18.02. Jefferies downgraded Rowan from Buy to Hold.
- CONSOL Energy Inc. CNX dropped 6 percent to $17.86. SunTrust Robinson Humphrey downgraded CONSOL Energy from Buy to Hold.
- Himax Technologies, Inc. (ADR) HIMX shares fell 5.2 percent to $5.13. Baird downgraded Himax from Outperform to Neutral.
- Novan Inc NOVN dropped 4.8 percent to $4.62 after dipping 74.01 percent on Friday.
- Paycom Software Inc PAYC declined 4.6 percent to $46.94. Pacific Crest downgraded Paycom Software from Overweight to Sector Weight.
- Barclays PLC (ADR) BCS fell 3 percent to $11.18. Berenberg downgraded Barclays from Hold to Sell.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: NewsMovers & ShakersIntraday UpdateMarketsAnalyst RatingsHealth CareMid-Day LosersPharmaceuticalsTop Losers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
